VABYSMO sol inj 6 mg/0.05 ml ser pré 0.175 ml
7680697090015
CH-69709
S01LA09
11.99.0.
Reimbursement limitations:
VABYSMO
Pour le traitement de la dégénérescence maculaire liée à l’âge exsudative (humide) (DMLA) ou d’une …
1 / 2
google
Details
- Product number
- 6970901
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- faricimabum 6 mg, histidinum, acidum aceticum 30 per centum ad pH, methioninum, natrii chloridum corresp. natrium 28 µg, saccharum, polysorbatum 20, aqua ad iniectabile, ad solutionem pro 0.05 ml.
Articles (1)
Vabysmo 6 mg/0.05 ml, Injektionslösung in einer Fertigspritze
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
6.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
28.0 UG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 920.00
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/04/2025
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 69709
- Drug name
- Vabysmo, Injektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- S01LA09
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 04/12/2024
- Authorization expiration date
- 03/12/2029
- IT number
- 11.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- VABYSMO sol inj 6 mg/0.05 ml ser pré 0.175 ml
- Description (DE)
- VABYSMO Inj Lös 6 mg/0.05 ml Fertspr 0.175 ml
- Market launch
- 04/12/2024
- Narcotic (BTM)
- No